Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Pediatric Immunology · Mendelian Susceptibility to Mycobacterial Disease due to Complete RORC Deficiency

Building Your Care Team and Managing Daily Life

At a Glance

Children with complete RORC deficiency benefit from coordinated care at an inborn errors of immunity center, careful infection and medication management, BCG avoidance, individualized vaccine guidance, and practical support for school, hygiene, travel, and family genetic planning.

Managing complete RORC deficiency requires a “village” of specialists who work together to protect your child. Because this condition is ultra-rare, your care team should ideally be based at a specialized center for Inborn Errors of Immunity (IEI). This ensures that the doctors treating the infections are in constant communication with the scientists understanding the underlying genetic defect [1][2].

Your Essential Care Team

A multidisciplinary approach is the gold standard for children with MSMD. Your team should include:

  • Pediatric Immunologist: The “captain” of the team. They focus on the underlying immune defect, monitoring cell counts (like MAIT and iNKT cells), and deciding if advanced therapies like interferon-gamma or HSCT are needed [1][3].
  • Pediatric Infectious Disease (ID) Specialist: The expert in “bugs and drugs.” They manage the complex, long-term antibiotic combinations needed to clear mycobacteria and keep Candida under control [2][4].
  • Medical Geneticist & Genetic Counselor: These specialists provide the definitive diagnosis and help you understand the autosomal recessive inheritance. They are vital for facilitating rapid targeted testing for newborn siblings, discussing reproductive options, and offering carrier testing for extended family [2][5].
  • Specialized Microbiologist: A behind-the-scenes expert who identifies the specific species of mycobacteria (like M. bovis from the BCG vaccine) to ensure the antibiotics being used are effective [2][6].
  • Pediatric Pharmacist: A critical resource for managing the many potential drug interactions and monitoring for organ toxicity from long-term treatment [7].

If you do not live near a specialized IEI center, ask your local immunologist about setting up teleconsultations or shared-care agreements with a major academic center.

Vetting Your Medical Team

When meeting new specialists, it is okay to be direct. You are your child’s best advocate. Consider asking:

  1. “Do you have experience treating Mendelian Susceptibility to Mycobacterial Disease (MSMD)?”
  2. “How do you coordinate care with the other specialists on the team?”
  3. “Does your lab have the capability to perform functional immune assays, such as measuring IL-17 and IFN-γ\gamma production?” [8]
  4. “What is your protocol for monitoring long-term medication side effects in young children?” [7]

Daily Life and Quality of Life

The goal of treatment is to allow your child to live a full, happy life while staying safe. Daily management focuses on “smart” prevention rather than isolation [9].

  • Hygiene and Skin Care: For children with chronic mucocutaneous candidiasis (CMC), skin and oral hygiene are supportive measures (they do not replace medical antifungal treatment). Use gentle cleansers, keep skin folds dry, and work with a pediatric dentist who understands the challenges of recurrent oral thrush [10][11].
  • Environmental Awareness: While your child should not live in a “bubble,” it is wise to avoid known sick contacts and use ordinary respiratory and hand hygiene. Ask your specialist before exposing your child to unusual environments, and follow their advice regarding food and water safety [12].
  • Vaccination Safety: Ensure every healthcare provider (including dentists and school nurses) knows that the BCG vaccine is strictly forbidden [13]. However, most inactivated (killed) vaccines are safe and recommended to protect your child from other common illnesses. The safety of live viral vaccines (like MMR or varicella) must be reviewed by your immunologist [14][15].
  • School and Socializing: If your child is clinically stable and their infections are well-managed, they should be encouraged to attend school and play with friends. Work with your immunologist to create a “School Health Plan” that outlines when they need to stay home and how the school should handle a fever [9][16].
  • Psychosocial Support: Navigating a rare, chronic illness is exhausting. Seek out support groups for primary immunodeficiencies for yourself, and consider psychological support for your child as they grow and begin managing their own care.

By building a team that values your input and understands the nuances of RORC deficiency, you can focus less on the “what ifs” and more on your child’s growth and development [9].

Common questions in this guide

What kind of care team does a child with complete RORC deficiency need?
Care is best coordinated through a center that specializes in inborn errors of immunity. The team may include a pediatric immunologist, infectious disease specialist, geneticist and counselor, microbiologist, and pediatric pharmacist, with regular communication among them.
Which vaccines should a child with complete RORC deficiency avoid?
BCG should not be given because it is a live mycobacterial vaccine. Most inactivated vaccines are generally safe and recommended, while live viral vaccines such as MMR or varicella should be reviewed with the child’s immunologist before administration.
Can children with complete RORC deficiency attend school and play with friends?
If the child is clinically stable and infections are controlled, attending school and socializing are generally encouraged. The family and immunologist can create a written school plan that explains when the child should stay home and what staff should do if fever develops.
How can families reduce infection risk at home without isolating their child?
Use ordinary hand and respiratory hygiene, avoid known sick contacts, keep skin folds clean and dry, and follow specialist advice about food and water. These measures support medical treatment but do not replace prescribed antibiotics or antifungal therapy, especially for recurrent Candida.
What should be monitored during long-term treatment for complete RORC deficiency?
Because treatment may involve several medicines, the care team should check for drug interactions, organ toxicity, and other side effects. A pediatric pharmacist and the treating specialists can help families follow the medication schedule and arrange needed laboratory monitoring.
Why is genetic counseling important for families affected by complete RORC deficiency?
Complete RORC deficiency follows an autosomal recessive inheritance pattern, so genetic counseling can explain carrier testing and the chance of recurrence in future pregnancies. The team can also discuss targeted testing for newborn siblings and relatives when appropriate.

Get notified when new evidence is published on Mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (16)
  1. 1

    Mendelian susceptibility to mycobacterial disease in tuberculosis-hyperendemic South Africa.

    Cornelissen HM, Glanzmann B, Van Coller A, et al.

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 2021; (111(10)):998-1005 doi:10.7196/SAMJ.2021.v111i10.15341.

    PMID: 34949297
  2. 2

    What We Have Here Is a Failure to Communicate: Interleukin-12 / Interferon-gamma Axis Defects and Mendelian Susceptibility to Mycobacterial Disease.

    Johnston AΜ, Rider NL, Freeman AF, et al.

    The journal of allergy and clinical immunology. In practice 2026; (14(7)):1529-1539 doi:10.1016/j.jaip.2026.02.026.

    PMID: 41786143
  3. 3

    Mendelian susceptibility to mycobacterial disease: IFN-γ-driven immunity collapse underlies heterogeneous infections.

    Qian M, Zhou J, Zhou Q, et al.

    Frontiers in immunology 2026; (17()):1781297 doi:10.3389/fimmu.2026.1781297.

    PMID: 42183200
  4. 4

    Clinical recommendations for diagnosis and management of Mendelian susceptibility to mycobacterial disease in resource-limited settings.

    Cornelissen H, Glanzmann B, van Coller A, et al.

    The journal of allergy and clinical immunology. Global 2025; (4(4)):100540 doi:10.1016/j.jacig.2025.100540.

    PMID: 41048447
  5. 5

    Laboratory evaluation of the IFN-γ circuit for the molecular diagnosis of Mendelian susceptibility to mycobacterial disease.

    Esteve-Solé A, Sologuren I, Martínez-Saavedra MT, et al.

    Critical reviews in clinical laboratory sciences 2018; (55(3)):184-204 doi:10.1080/10408363.2018.1444580.

    PMID: 29502462
  6. 6

    Pediatric Mycobacterium bovis Infection: Clinical Spectrum, BCG-Related Disease, Primary Immunodeficiency, and a Comprehensive Review of the Literature.

    Mete Atasever N, Dede E, Köksalan K, et al.

    Vaccines 2026; (14(10)) doi:10.3390/vaccines14100867.

    PMID: 42931396
  7. 7

    Disseminated Bacillus Calmette-Guérin and Susceptibility to Mycobacterial Infections-Implications on Bacillus Calmette-Guérin Vaccinations.

    Lee PP

    Annals of the Academy of Medicine, Singapore 2015; (44(8)):297-301.

    PMID: 26477962
  8. 8

    Mendelian susceptibility to mycobacterial disease: Clinical, immunological, and genetic study in India.

    Dalvi A, Temkar L, Desai M, et al.

    Journal of human immunity 2026; (2(1)):e20250153 doi:10.70962/jhi.20250153.

    PMID: 42170591
  9. 9

    Shared Decision-Making and Health-Related Quality of Life in the Diagnosis and Management of Patients With Inborn Errors of Immunity.

    Lawrence MG, Kim VHD, Orange JS, Scherzer R

    The journal of allergy and clinical immunology. In practice 2026; doi:10.1016/j.jaip.2026.07.010.

    PMID: 42447994
  10. 10

    Oesophageal candidiasis and squamous cell cancer in patients with gain-of-function STAT1 gene mutation.

    Koo S, Kejariwal D, Al-Shehri T, et al.

    United European gastroenterology journal 2017; (5(5)):625-631 doi:10.1177/2050640616684404.

    PMID: 28815025
  11. 11

    Autosomal dominant chronic mucocutaneous candidiasis with STAT1 mutation can be associated with chronic active hepatitis: A case report.

    Liu L, Huang Y, Liao Y, Shu S

    Frontiers in pediatrics 2022; (10()):990729 doi:10.3389/fped.2022.990729.

    PMID: 36683786
  12. 12

    [Recommendations for care, prevention of infections and chemoprophylaxis in inborn errors of immunity].

    Villa M, Merhar C, Nievas E, et al.

    Archivos argentinos de pediatria 2023; (121(1)):e202202885 doi:10.5546/aap.2022-02885.

    PMID: 36701243
  13. 13

    Mendelian Susceptibility to Mycobacterial Disease (MSMD): Clinical, Immunological, and Genetic Features of 22 Patients from 15 Moroccan Kindreds.

    Errami A, Baghdadi JE, Ailal F, et al.

    Journal of clinical immunology 2023; (43(4)):728-740 doi:10.1007/s10875-022-01419-x.

    PMID: 36630059
  14. 14

    Vaccination in Primary Immunodeficiency Disorders.

    Sobh A, Bonilla FA

    The journal of allergy and clinical immunology. In practice 2016; (4(6)):1066-1075 doi:10.1016/j.jaip.2016.09.012.

    PMID: 27836056
  15. 15

    Immunizing the imperfect immune system: Coronavirus disease 2019 vaccination in patients with inborn errors of immunity.

    Durkee-Shock JR, Keller MD

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2022; (129(5)):562-571.e1 doi:10.1016/j.anai.2022.06.009.

    PMID: 35718282
  16. 16

    Inborn errors of immunity: a structured model for paediatric-to-adult transition of care.

    Civino A, Diomeda F, D'Orio C, et al.

    Frontiers in immunology 2026; (17()):1813944 doi:10.3389/fimmu.2026.1813944.

    PMID: 42199435

This page offers general information for caregivers of children with complete RORC deficiency and does not replace medical advice. Follow your child’s immunology and infectious disease team for vaccine, infection, medication, and travel decisions.